Pharmaceutical Inc. Ultragenyx serves as Executive at Arcturus Therapeutics Holdings Inc., where they oversee executive responsibilities. Since joining the company, Pharmaceutical Inc. Ultragenyx has executed 5 insider transactions totaling $124.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 11, 2021 involved selling 75,000 shares valued at $3.4M.
Pharmaceutical Inc. Ultragenyx currently holds 1,400,000 shares of Arcturus Therapeutics Holdings Inc. (ARCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pharmaceutical Inc. Ultragenyx has been a net seller of ARCT stock. They have purchased $0 and sold $124.3M worth of shares.
Pharmaceutical Inc. Ultragenyx's most recent insider trade was on Aug 11, 2021, when they sold 75,000 shares at $45.83 per share.
Get notified when new Form 4 filings are submitted
| $55.44 |
| Discretionary |
| Dec 9, 2020 | ARCT | $34.0M | Sale | 357,745 | $94.97 | Discretionary |
| Dec 8, 2020 | ARCT | $46.7M | Sale | 442,255 | $105.54 | Discretionary |
| May 20, 2020 | ARCT | $9.6M | Option Exercise | 600,000 | $16.00 | Discretionary |